Loss of market exclusivity, impact of the Hatch-Waxman Act, and substitution and bioequivalence are just some of the forces that will drive the generic medication industry into the future.
Health care spending by the federal government, patients, and
third-party payers is driven by many factors, including the price paid
for the prescription drug dispensed.